Nicholas C Turner Selected Research

Gemcitabine

10/2021

Niraparib for Advanced Breast Cancer with Germline BRCA1 and BRCA2 Mutations: the EORTC 1307-BCG/BIG5-13/TESARO PR-30-50-10-C BRAVO Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicholas C Turner Research Topics

Disease

72	Breast Neoplasms (Breast Cancer) 04/2024 - 08/2006
53	Neoplasms (Cancer) 11/2023 - 02/2008
8	Neutropenia 01/2021 - 07/2015
6	Triple Negative Breast Neoplasms 12/2023 - 12/2010
6	Disease Progression 06/2023 - 07/2015
4	Infections 01/2021 - 01/2017
3	Exanthema (Rash) 06/2023 - 10/2020
3	Febrile Neutropenia 01/2021 - 07/2015
3	Fatigue 10/2020 - 07/2015
2	Diarrhea 06/2023 - 10/2020
2	Ovarian Neoplasms (Ovarian Cancer) 11/2017 - 01/2016
2	Leukopenia 01/2017 - 07/2015
2	Lung Neoplasms (Lung Cancer) 01/2015 - 12/2010
1	Brain Neoplasms (Brain Tumor) 10/2022
1	Lobular Carcinoma 04/2022
1	Circulating Neoplastic Cells 01/2022
1	Microsatellite Instability 01/2022
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Genetic Translocation (Chromosomal Translocation) 01/2017
1	Cholangiocarcinoma 01/2017
1	Neoplasm Metastasis (Metastasis) 04/2016
1	Bone Diseases (Bone Disease) 04/2016
1	Stomach Neoplasms (Stomach Cancer) 01/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2016
1	Glioblastoma (Glioblastoma Multiforme) 01/2016
1	Melanoma (Melanoma, Malignant) 01/2016

Drug/Important Bio-Agent (IBA)

25	Hormones (Hormone)IBA 12/2023 - 07/2015
24	palbociclibIBA 01/2024 - 07/2015
21	Fulvestrant (Faslodex)FDA Link 11/2023 - 07/2015
15	Circulating Tumor DNAIBA 12/2023 - 08/2015
15	Estrogen ReceptorsIBA 11/2023 - 08/2011
11	ErbB Receptors (EGF Receptor)IBA 06/2023 - 07/2015
9	Phosphotransferases (Kinase)IBA 04/2024 - 08/2011
9	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2016
8	Cyclin-Dependent Kinase 4IBA 06/2023 - 01/2017
7	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 01/2013
7	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2020 - 05/2008
6	capivasertibIBA 04/2024 - 01/2020
6	Cyclin-Dependent Kinases (cdk Proteins)IBA 12/2023 - 02/2015
4	PlatinumIBA 01/2019 - 11/2012
3	AlpelisibIBA 04/2024 - 01/2022
3	Aromatase InhibitorsIBA 06/2023 - 01/2016
3	Cell-Free Nucleic AcidsIBA 01/2022 - 11/2017
3	Phenobarbital (Luminal)FDA Link 11/2020 - 12/2013
3	human ERBB2 proteinIBA 01/2020 - 10/2016
3	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 06/2012 - 12/2010
2	taxaneIBA 12/2023 - 01/2013
2	Immune Checkpoint InhibitorsIBA 12/2023 - 01/2022
2	Gonadotropin-Releasing Hormone (GnRH)FDA Link 11/2023 - 01/2017
2	talazoparibIBA 10/2023 - 01/2019
2	neratinibIBA 10/2022 - 10/2020
2	Vinorelbine (Navelbine)FDA LinkGeneric 10/2022 - 10/2021
2	Capecitabine (Xeloda)FDA Link 10/2022 - 10/2021
2	eribulin FDA Link 10/2022 - 10/2021
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2022 - 10/2020
2	Paclitaxel (Taxol)FDA LinkGeneric 10/2020 - 01/2020
2	exemestane (Aromasin)FDA Link 10/2020 - 01/2016
2	olaparibIBA 10/2020 - 01/2017
2	CyclinsIBA 10/2019 - 01/2016
2	LigandsIBA 06/2012 - 08/2011
2	Proteins (Proteins, Gene)FDA Link 12/2008 - 08/2006
1	Everolimus FDA Link 04/2024
1	130-nm albumin-bound paclitaxelIBA 12/2023
1	ipatasertibIBA 12/2023
1	atezolizumabIBA 12/2023
1	giredestrantIBA 11/2023
1	Estrogen Receptor AntagonistsIBA 11/2023
1	TubulinIBA 10/2022
1	Tubulin ModulatorsIBA 10/2022
1	Cell Adhesion MoleculesIBA 04/2022
1	Cadherins (E-Cadherin)IBA 04/2022
1	N 30IBA 01/2022
1	pembrolizumabIBA 01/2022
1	ribociclibIBA 01/2022
1	dostarlimabIBA 01/2022
1	niraparibIBA 10/2021
1	Gemcitabine FDA Link 10/2021
1	tetrachloroisophthalonitrile (Bravo)IBA 10/2021
1	Ado-Trastuzumab EmtansineIBA 10/2021
1	2- (3- (2- (1- isopropyl- 3- methyl- 1H- 1,2- 4- triazol- 5- yl)- 5,6- dihydrobenzo(f)imidazo(1,2- d)(1,4)oxazepin- 9- yl)- 1H- pyrazol- 1- yl)- 2- methylpropanamideIBA 01/2021
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 10/2020
1	rucaparibIBA 01/2020
1	E-3810IBA 01/2020
1	InterferonsIBA 01/2020
1	Tyrosine Kinase InhibitorsIBA 01/2019
1	Goserelin (Zoladex)FDA Link 01/2017
1	Therapeutic UsesIBA 01/2017
1	SaltsIBA 01/2017
1	adavosertibIBA 01/2017
1	Anastrozole (Arimidex)FDA LinkGeneric 01/2016

Therapy/Procedure

49	Therapeutics 04/2024 - 02/2008
15	Drug Therapy (Chemotherapy) 10/2023 - 12/2010
3	Adjuvant Chemotherapy 10/2021 - 10/2019
3	Neoadjuvant Therapy 10/2019 - 12/2010
2	Radiotherapy 01/2022 - 01/2020
1	Aftercare (After-Treatment) 06/2023
1	Drug Tapering 10/2016
1	Intramuscular Injections 04/2016